{"id":"F2006L00936","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 13 of 2006)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-2006","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":58224,"registerId":"commonwealth-F2006L00936-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 13 of 2006)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 13 OF 2006\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 April 2006.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nAlteplase\n\nCarbachol\n\nDiflunisal\n\nTetanus Vaccine - Adsorbed\n\nDated this twenty fourth day of March 2006.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1747},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This declaration performs exactly the standard administrative function intended by section 85(2AA) of the National Health Act 1953 — removing specific pharmaceutical benefits from the scheme following expert committee advice. It represents a routine PBS listing update without expansion beyond the legislative purpose."},"complexity_factors":["Single-page instrument with only four items listed in the Schedule","No conditional logic, exceptions, or transitional provisions","Straightforward administrative delisting without operative complexity","Minimal cross-referencing (only cites the empowering section 85(2AA) of the National Health Act 1953)"],"plain_english_summary":"This declaration removes four medicines from Australia’s Pharmaceutical Benefits Scheme from 1 April 2006, so they are no longer federally subsidised: alteplase, carbachol, diflunisal and the adsorbed tetanus vaccine. Affected patients must pay commercial prices unless covered by hospital provision, private insurance or another program; the change follows expert committee review."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-2006","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-2006/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-2006/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-2006/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-2006/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-2006/documents"}}